Novo Nordisk loses court case against Sanofi over Danish press statement

French pharmaceutical company Sanofi has won a case at the Danish Maritime and Commercial Court on Novo Nordisk's home ground on violations of Marketing Practices Act.

Photo: Stine Tidsvilde

Novo Nordisk was just served a punch to the stomach on its home turf in Denmark and has lost a major legal in-fight against its arch rival Sanofi, after the Danish Maritime and Commercial High Court judged in favor of Sanofi on every count, more or less.

This means the Danish pharmaceutical giant has to make an extensive rectification and needs to pay a major fine.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs